Page last updated: 2024-09-03

ym 529 and osteoprotegerin

ym 529 has been researched along with osteoprotegerin in 3 studies

Compound Research Comparison

Studies
(ym 529)
Trials
(ym 529)
Recent Studies (post-2010)
(ym 529)
Studies
(osteoprotegerin)
Trials
(osteoprotegerin)
Recent Studies (post-2010) (osteoprotegerin)
14023715,1082122,726

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cui, N; Guo, C; Hashimoto, S; Noma, H; Nomura, T; Okamoto, M; Sato, M; Shibahala, T; Takagi, R; Yokoo, K; Yu, G1
Fukata, S; Hagino, H; Kishimoto, Y; Mizumura, H; Tanishima, S; Teshima, R1
Masuda, H; Tanaka, S1

Reviews

1 review(s) available for ym 529 and osteoprotegerin

ArticleYear
[Drugs under development for osteoporosis ].
    Nihon rinsho. Japanese journal of clinical medicine, 2009, Volume: 67, Issue:5

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Cathepsin K; Cathepsins; Denosumab; Diphosphonates; Drug Design; Humans; Ibandronic Acid; Imidazoles; Organometallic Compounds; Osteoporosis; Osteoprotegerin; RANK Ligand; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes

2009

Other Studies

2 other study(ies) available for ym 529 and osteoprotegerin

ArticleYear
Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Apr-01, Volume: 11, Issue:7

    Topics: Animals; Body Weight; Bone Resorption; Carcinoma, Squamous Cell; Carrier Proteins; Cell Line, Tumor; Diphosphonates; Disease Models, Animal; Gene Expression; Glycoproteins; Imaging, Three-Dimensional; Imidazoles; Interleukin-6; Male; Mandible; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Mouth Neoplasms; Neoplasm Invasiveness; Osteoclasts; Osteoprotegerin; Parathyroid Hormone-Related Protein; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha

2005
Minodronic acid influences receptor activator of nuclear factor kappaB ligand expression and suppresses bone resorption by osteoclasts in rats with collagen-induced arthritis.
    Modern rheumatology, 2007, Volume: 17, Issue:3

    Topics: Animals; Arthritis, Experimental; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Disease Models, Animal; Female; Imidazoles; Osteoprotegerin; RANK Ligand; Rats; Rats, Sprague-Dawley

2007